Author:
Koseki Mako,Yoshito Nishimura,Elias Evelyn,Estaris Jonathan,Chesta Fnu,Takaoka Kensuke,Shao Theresa,Horita Nobuyuki,Fujiwara Yu
Reference19 articles.
1. Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury;H Abu-Sbeih;J Immunother Cancer,2019
2. Immune-related pancreatitis due to anti-PD-L1 therapy in a patient with non-small cell lung cancer: A case report;J Malet;Medicine,2022
3. Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients;R Rom�o;Survival: Single Center Experience and Literature Review. Cancers (Basel),2023
4. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade;M A Postow;N Engl J Med,2018